DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $407,998 | -46.0% | 20,238 | 0.0% | 0.01% | -45.5% |
| Q2 2021 | $755,282 | +52.2% | 20,238 | +4.3% | 0.01% | +57.1% |
| Q1 2021 | $496,288 | +12.4% | 19,409 | -3.2% | 0.01% | 0.0% |
| Q4 2020 | $441,702 | +22.5% | 20,050 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $360,700 | -29.2% | 20,050 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $509,270 | +53.1% | 20,050 | +10.7% | 0.01% | +28.6% |
| Q1 2020 | $332,681 | -16.6% | 18,110 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $398,963 | +53.4% | 18,110 | 0.0% | 0.01% | +75.0% |
| Q3 2019 | $260,060 | -8.8% | 18,110 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $285,232 | +13.0% | 18,110 | +5.1% | 0.01% | 0.0% |
| Q1 2019 | $252,434 | +27.9% | 17,231 | -6.7% | 0.01% | +25.0% |
| Q4 2018 | $197,434 | -15.6% | 18,469 | +20.5% | 0.00% | 0.0% |
| Q3 2018 | $233,982 | -99.9% | 15,333 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $187,830,000 | +133112.8% | 15,333 | +29.2% | 0.00% | +200.0% |
| Q4 2015 | $141,000 | – | 11,866 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|